Buprenorphine

Sujin Lee Weinstein, PharmD, BCPP

INDICATIONS

FDA

  • Opioid use disorder (OUD), induction & maintenance, pain management (pain management with buprenorphine will reviewed in a separate module)

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.